Global High Performance Medical Plastics Market Overview

High Performance Medical Plastics Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2019, growing at a CAGR of xx% globally.

Introspective Market Research provides the newest industry data about High Performance Medical Plastics Market and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. The High Performance Medical Plastics industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Scope of the High Performance Medical Plastics Market

The main goal of this report is to help users understand the High Performance Medical Plastics market in terms of its definition, segmentation, market potential, influential trends, and challenges facing the market. In-depth research and analysis took place while preparing the report. Readers will find this report very helpful to in-depth understanding of the market.

Market Segmentation



Players Covered in High Performance Medical Plastics market are :

  • Solvay SA (Belgium)
  • SABIC (UAE)
  • Mitsubishi Chemical Corporation (Japan)
  • Evonik Industries AG (Germany)
  • Arkema SA (France)
  • Ensinger (Germany)
  • Victrex PLC (UK)
  • Rochling SE & Co. AG (Germany)
  • Raumedic AG (Germany)
  • The Chemours Company (US)
  • DuPont (US)
  • Saint-Gobain Performance Plastic (France)
  • Celanese Corporation (US)
  • Trelleborg (Sweden)
  • Tekni-Plex (US)
  • Biomerics (US)
  • RTP Company (US)
  • Gujrat Fluorochemicals Ltd. (India)
  • Drake Medical Plastic (US)
  • Performance Plastic Ltd. (US)
  • Bollinger Group (Austria)
  • China Array Plastic (China)
  • Extra Plastic Industry Co. Ltd. (Taiwan)
  • Spectrum Plastic Group (Atlanta)
  • Stratasys (Israel)

High Performance Medical Plastics Market - Insights & Analysis
Segmentations by Type
  • Fluoropolymers (FP)
  • High Performance Polyamides (HPPA)
  • Polyaryletherketones (PAEK)
  • Polyphenylene Sulfides (PPS)
  • Polyetherimide (PEI)
  • Others (PAI; PFA; ETFE; and PEK)
by Application
  • Medical Equipment & Tools
  • Medical Supplies
  • Drug Delivery
  • Prosthesis & Implants
  • Therapeutic System
  • Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: High Performance Medical Plastics Market by Type
 4.1 High Performance Medical Plastics Market Overview Snapshot and Growth Engine
 4.2 High Performance Medical Plastics Market Overview
 4.3 Fluoropolymers (FP)
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Fluoropolymers (FP): Grographic Segmentation
 4.4 High Performance Polyamides (HPPA)
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 High Performance Polyamides (HPPA): Grographic Segmentation
 4.5 Polyaryletherketones (PAEK)
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Polyaryletherketones (PAEK): Grographic Segmentation
 4.6 Polyphenylene Sulfides (PPS)
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size (2016-2028F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Polyphenylene Sulfides (PPS): Grographic Segmentation
 4.7 Polyetherimide (PEI)
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size (2016-2028F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Polyetherimide (PEI): Grographic Segmentation
 4.8 Others (PAI; PFA; ETFE; and PEK)
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size (2016-2028F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 Others (PAI; PFA; ETFE; and PEK): Grographic Segmentation

Chapter 5: High Performance Medical Plastics Market by Application
 5.1 High Performance Medical Plastics Market Overview Snapshot and Growth Engine
 5.2 High Performance Medical Plastics Market Overview
 5.3 Medical Equipment & Tools
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Medical Equipment & Tools: Grographic Segmentation
 5.4 Medical Supplies
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Medical Supplies: Grographic Segmentation
 5.5 Drug Delivery
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Drug Delivery: Grographic Segmentation
 5.6 Prosthesis & Implants
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Prosthesis & Implants: Grographic Segmentation
 5.7 Therapeutic System
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Therapeutic System: Grographic Segmentation
 5.8 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size (2016-2028F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries): Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 High Performance Medical Plastics Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 High Performance Medical Plastics Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 High Performance Medical Plastics Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 SOLVAY SA (BELGIUM)
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 SABIC (UAE)
 6.4 MITSUBISHI CHEMICAL CORPORATION (JAPAN)
 6.5 EVONIK INDUSTRIES AG (GERMANY)
 6.6 ARKEMA SA (FRANCE)
 6.7 ENSINGER (GERMANY)
 6.8 VICTREX PLC (UK)
 6.9 ROCHLING SE & CO. AG (GERMANY)
 6.10 RAUMEDIC AG (GERMANY)
 6.11 THE CHEMOURS COMPANY (US)
 6.12 DUPONT (US)
 6.13 SAINT-GOBAIN PERFORMANCE PLASTIC (FRANCE)
 6.14 CELANESE CORPORATION (US)
 6.15 TRELLEBORG (SWEDEN)
 6.16 TEKNI-PLEX (US)
 6.17 BIOMERICS (US)
 6.18 RTP COMPANY (US)
 6.19 GUJRAT FLUOROCHEMICALS LTD. (INDIA)
 6.20 DRAKE MEDICAL PLASTIC (US)
 6.21 PERFORMANCE PLASTIC LTD. (US)
 6.22 BOLLINGER GROUP (AUSTRIA)
 6.23 CHINA ARRAY PLASTIC (CHINA)
 6.24 EXTRA PLASTIC INDUSTRY CO. LTD. (TAIWAN)
 6.25 SPECTRUM PLASTIC GROUP (ATLANTA)
 6.26 STRATASYS (ISRAEL)

Chapter 7: Global High Performance Medical Plastics Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Type
  7.2.1 Fluoropolymers (FP)
  7.2.2 High Performance Polyamides (HPPA)
  7.2.3 Polyaryletherketones (PAEK)
  7.2.4 Polyphenylene Sulfides (PPS)
  7.2.5 Polyetherimide (PEI)
  7.2.6 Others (PAI; PFA; ETFE; and PEK)
 7.3 Historic and Forecasted Market Size By Application
  7.3.1 Medical Equipment & Tools
  7.3.2 Medical Supplies
  7.3.3 Drug Delivery
  7.3.4 Prosthesis & Implants
  7.3.5 Therapeutic System
  7.3.6 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)

Chapter 8: North America High Performance Medical Plastics Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Type
  8.4.1 Fluoropolymers (FP)
  8.4.2 High Performance Polyamides (HPPA)
  8.4.3 Polyaryletherketones (PAEK)
  8.4.4 Polyphenylene Sulfides (PPS)
  8.4.5 Polyetherimide (PEI)
  8.4.6 Others (PAI; PFA; ETFE; and PEK)
 8.5 Historic and Forecasted Market Size By Application
  8.5.1 Medical Equipment & Tools
  8.5.2 Medical Supplies
  8.5.3 Drug Delivery
  8.5.4 Prosthesis & Implants
  8.5.5 Therapeutic System
  8.5.6 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe High Performance Medical Plastics Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Fluoropolymers (FP)
  9.4.2 High Performance Polyamides (HPPA)
  9.4.3 Polyaryletherketones (PAEK)
  9.4.4 Polyphenylene Sulfides (PPS)
  9.4.5 Polyetherimide (PEI)
  9.4.6 Others (PAI; PFA; ETFE; and PEK)
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Medical Equipment & Tools
  9.5.2 Medical Supplies
  9.5.3 Drug Delivery
  9.5.4 Prosthesis & Implants
  9.5.5 Therapeutic System
  9.5.6 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific High Performance Medical Plastics Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Fluoropolymers (FP)
  10.4.2 High Performance Polyamides (HPPA)
  10.4.3 Polyaryletherketones (PAEK)
  10.4.4 Polyphenylene Sulfides (PPS)
  10.4.5 Polyetherimide (PEI)
  10.4.6 Others (PAI; PFA; ETFE; and PEK)
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Medical Equipment & Tools
  10.5.2 Medical Supplies
  10.5.3 Drug Delivery
  10.5.4 Prosthesis & Implants
  10.5.5 Therapeutic System
  10.5.6 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America High Performance Medical Plastics Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Fluoropolymers (FP)
  11.4.2 High Performance Polyamides (HPPA)
  11.4.3 Polyaryletherketones (PAEK)
  11.4.4 Polyphenylene Sulfides (PPS)
  11.4.5 Polyetherimide (PEI)
  11.4.6 Others (PAI; PFA; ETFE; and PEK)
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Medical Equipment & Tools
  11.5.2 Medical Supplies
  11.5.3 Drug Delivery
  11.5.4 Prosthesis & Implants
  11.5.5 Therapeutic System
  11.5.6 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa High Performance Medical Plastics Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Fluoropolymers (FP)
  12.4.2 High Performance Polyamides (HPPA)
  12.4.3 Polyaryletherketones (PAEK)
  12.4.4 Polyphenylene Sulfides (PPS)
  12.4.5 Polyetherimide (PEI)
  12.4.6 Others (PAI; PFA; ETFE; and PEK)
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Medical Equipment & Tools
  12.5.2 Medical Supplies
  12.5.3 Drug Delivery
  12.5.4 Prosthesis & Implants
  12.5.5 Therapeutic System
  12.5.6 Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion
High Performance Medical Plastics Market - Insights & Analysis
Segmentations by Type
  • Fluoropolymers (FP)
  • High Performance Polyamides (HPPA)
  • Polyaryletherketones (PAEK)
  • Polyphenylene Sulfides (PPS)
  • Polyetherimide (PEI)
  • Others (PAI; PFA; ETFE; and PEK)
by Application
  • Medical Equipment & Tools
  • Medical Supplies
  • Drug Delivery
  • Prosthesis & Implants
  • Therapeutic System
  • Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries)
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. HIGH PERFORMANCE MEDICAL PLASTICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. HIGH PERFORMANCE MEDICAL PLASTICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. HIGH PERFORMANCE MEDICAL PLASTICS MARKET COMPETITIVE RIVALRY
TABLE 005. HIGH PERFORMANCE MEDICAL PLASTICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. HIGH PERFORMANCE MEDICAL PLASTICS MARKET THREAT OF SUBSTITUTES
TABLE 007. HIGH PERFORMANCE MEDICAL PLASTICS MARKET BY TYPE
TABLE 008. FLUOROPOLYMERS (FP) MARKET OVERVIEW (2016-2028)
TABLE 009. HIGH PERFORMANCE POLYAMIDES (HPPA) MARKET OVERVIEW (2016-2028)
TABLE 010. POLYARYLETHERKETONES (PAEK) MARKET OVERVIEW (2016-2028)
TABLE 011. POLYPHENYLENE SULFIDES (PPS) MARKET OVERVIEW (2016-2028)
TABLE 012. POLYETHERIMIDE (PEI) MARKET OVERVIEW (2016-2028)
TABLE 013. OTHERS (PAI; PFA; ETFE; AND PEK) MARKET OVERVIEW (2016-2028)
TABLE 014. HIGH PERFORMANCE MEDICAL PLASTICS MARKET BY APPLICATION
TABLE 015. MEDICAL EQUIPMENT & TOOLS MARKET OVERVIEW (2016-2028)
TABLE 016. MEDICAL SUPPLIES MARKET OVERVIEW (2016-2028)
TABLE 017. DRUG DELIVERY MARKET OVERVIEW (2016-2028)
TABLE 018. PROSTHESIS & IMPLANTS MARKET OVERVIEW (2016-2028)
TABLE 019. THERAPEUTIC SYSTEM MARKET OVERVIEW (2016-2028)
TABLE 020. OTHERS (ARTIFICIAL CORNEA; CHEMICAL TANKS; STERILIZING BOXES; SECRETION BOTTLES; AND SURGICAL THEATER LUMINARIES) MARKET OVERVIEW (2016-2028)
TABLE 021. NORTH AMERICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE (2016-2028)
TABLE 022. NORTH AMERICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION (2016-2028)
TABLE 023. N HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY COUNTRY (2016-2028)
TABLE 024. EUROPE HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE (2016-2028)
TABLE 025. EUROPE HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION (2016-2028)
TABLE 026. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY COUNTRY (2016-2028)
TABLE 027. ASIA PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE (2016-2028)
TABLE 028. ASIA PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION (2016-2028)
TABLE 029. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY COUNTRY (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE (2016-2028)
TABLE 031. MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION (2016-2028)
TABLE 032. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY COUNTRY (2016-2028)
TABLE 033. SOUTH AMERICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY TYPE (2016-2028)
TABLE 034. SOUTH AMERICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY APPLICATION (2016-2028)
TABLE 035. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, BY COUNTRY (2016-2028)
TABLE 036. SOLVAY SA (BELGIUM): SNAPSHOT
TABLE 037. SOLVAY SA (BELGIUM): BUSINESS PERFORMANCE
TABLE 038. SOLVAY SA (BELGIUM): PRODUCT PORTFOLIO
TABLE 039. SOLVAY SA (BELGIUM): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. SABIC (UAE): SNAPSHOT
TABLE 040. SABIC (UAE): BUSINESS PERFORMANCE
TABLE 041. SABIC (UAE): PRODUCT PORTFOLIO
TABLE 042. SABIC (UAE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. MITSUBISHI CHEMICAL CORPORATION (JAPAN): SNAPSHOT
TABLE 043. MITSUBISHI CHEMICAL CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 044. MITSUBISHI CHEMICAL CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 045. MITSUBISHI CHEMICAL CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. EVONIK INDUSTRIES AG (GERMANY): SNAPSHOT
TABLE 046. EVONIK INDUSTRIES AG (GERMANY): BUSINESS PERFORMANCE
TABLE 047. EVONIK INDUSTRIES AG (GERMANY): PRODUCT PORTFOLIO
TABLE 048. EVONIK INDUSTRIES AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. ARKEMA SA (FRANCE): SNAPSHOT
TABLE 049. ARKEMA SA (FRANCE): BUSINESS PERFORMANCE
TABLE 050. ARKEMA SA (FRANCE): PRODUCT PORTFOLIO
TABLE 051. ARKEMA SA (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. ENSINGER (GERMANY): SNAPSHOT
TABLE 052. ENSINGER (GERMANY): BUSINESS PERFORMANCE
TABLE 053. ENSINGER (GERMANY): PRODUCT PORTFOLIO
TABLE 054. ENSINGER (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. VICTREX PLC (UK): SNAPSHOT
TABLE 055. VICTREX PLC (UK): BUSINESS PERFORMANCE
TABLE 056. VICTREX PLC (UK): PRODUCT PORTFOLIO
TABLE 057. VICTREX PLC (UK): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. ROCHLING SE & CO. AG (GERMANY): SNAPSHOT
TABLE 058. ROCHLING SE & CO. AG (GERMANY): BUSINESS PERFORMANCE
TABLE 059. ROCHLING SE & CO. AG (GERMANY): PRODUCT PORTFOLIO
TABLE 060. ROCHLING SE & CO. AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. RAUMEDIC AG (GERMANY): SNAPSHOT
TABLE 061. RAUMEDIC AG (GERMANY): BUSINESS PERFORMANCE
TABLE 062. RAUMEDIC AG (GERMANY): PRODUCT PORTFOLIO
TABLE 063. RAUMEDIC AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. THE CHEMOURS COMPANY (US): SNAPSHOT
TABLE 064. THE CHEMOURS COMPANY (US): BUSINESS PERFORMANCE
TABLE 065. THE CHEMOURS COMPANY (US): PRODUCT PORTFOLIO
TABLE 066. THE CHEMOURS COMPANY (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. DUPONT (US): SNAPSHOT
TABLE 067. DUPONT (US): BUSINESS PERFORMANCE
TABLE 068. DUPONT (US): PRODUCT PORTFOLIO
TABLE 069. DUPONT (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. SAINT-GOBAIN PERFORMANCE PLASTIC (FRANCE): SNAPSHOT
TABLE 070. SAINT-GOBAIN PERFORMANCE PLASTIC (FRANCE): BUSINESS PERFORMANCE
TABLE 071. SAINT-GOBAIN PERFORMANCE PLASTIC (FRANCE): PRODUCT PORTFOLIO
TABLE 072. SAINT-GOBAIN PERFORMANCE PLASTIC (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. CELANESE CORPORATION (US): SNAPSHOT
TABLE 073. CELANESE CORPORATION (US): BUSINESS PERFORMANCE
TABLE 074. CELANESE CORPORATION (US): PRODUCT PORTFOLIO
TABLE 075. CELANESE CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. TRELLEBORG (SWEDEN): SNAPSHOT
TABLE 076. TRELLEBORG (SWEDEN): BUSINESS PERFORMANCE
TABLE 077. TRELLEBORG (SWEDEN): PRODUCT PORTFOLIO
TABLE 078. TRELLEBORG (SWEDEN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. TEKNI-PLEX (US): SNAPSHOT
TABLE 079. TEKNI-PLEX (US): BUSINESS PERFORMANCE
TABLE 080. TEKNI-PLEX (US): PRODUCT PORTFOLIO
TABLE 081. TEKNI-PLEX (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. BIOMERICS (US): SNAPSHOT
TABLE 082. BIOMERICS (US): BUSINESS PERFORMANCE
TABLE 083. BIOMERICS (US): PRODUCT PORTFOLIO
TABLE 084. BIOMERICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. RTP COMPANY (US): SNAPSHOT
TABLE 085. RTP COMPANY (US): BUSINESS PERFORMANCE
TABLE 086. RTP COMPANY (US): PRODUCT PORTFOLIO
TABLE 087. RTP COMPANY (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. GUJRAT FLUOROCHEMICALS LTD. (INDIA): SNAPSHOT
TABLE 088. GUJRAT FLUOROCHEMICALS LTD. (INDIA): BUSINESS PERFORMANCE
TABLE 089. GUJRAT FLUOROCHEMICALS LTD. (INDIA): PRODUCT PORTFOLIO
TABLE 090. GUJRAT FLUOROCHEMICALS LTD. (INDIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. DRAKE MEDICAL PLASTIC (US): SNAPSHOT
TABLE 091. DRAKE MEDICAL PLASTIC (US): BUSINESS PERFORMANCE
TABLE 092. DRAKE MEDICAL PLASTIC (US): PRODUCT PORTFOLIO
TABLE 093. DRAKE MEDICAL PLASTIC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. PERFORMANCE PLASTIC LTD. (US): SNAPSHOT
TABLE 094. PERFORMANCE PLASTIC LTD. (US): BUSINESS PERFORMANCE
TABLE 095. PERFORMANCE PLASTIC LTD. (US): PRODUCT PORTFOLIO
TABLE 096. PERFORMANCE PLASTIC LTD. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 096. BOLLINGER GROUP (AUSTRIA): SNAPSHOT
TABLE 097. BOLLINGER GROUP (AUSTRIA): BUSINESS PERFORMANCE
TABLE 098. BOLLINGER GROUP (AUSTRIA): PRODUCT PORTFOLIO
TABLE 099. BOLLINGER GROUP (AUSTRIA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 099. CHINA ARRAY PLASTIC (CHINA): SNAPSHOT
TABLE 100. CHINA ARRAY PLASTIC (CHINA): BUSINESS PERFORMANCE
TABLE 101. CHINA ARRAY PLASTIC (CHINA): PRODUCT PORTFOLIO
TABLE 102. CHINA ARRAY PLASTIC (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. EXTRA PLASTIC INDUSTRY CO. LTD. (TAIWAN): SNAPSHOT
TABLE 103. EXTRA PLASTIC INDUSTRY CO. LTD. (TAIWAN): BUSINESS PERFORMANCE
TABLE 104. EXTRA PLASTIC INDUSTRY CO. LTD. (TAIWAN): PRODUCT PORTFOLIO
TABLE 105. EXTRA PLASTIC INDUSTRY CO. LTD. (TAIWAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. SPECTRUM PLASTIC GROUP (ATLANTA): SNAPSHOT
TABLE 106. SPECTRUM PLASTIC GROUP (ATLANTA): BUSINESS PERFORMANCE
TABLE 107. SPECTRUM PLASTIC GROUP (ATLANTA): PRODUCT PORTFOLIO
TABLE 108. SPECTRUM PLASTIC GROUP (ATLANTA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. STRATASYS (ISRAEL): SNAPSHOT
TABLE 109. STRATASYS (ISRAEL): BUSINESS PERFORMANCE
TABLE 110. STRATASYS (ISRAEL): PRODUCT PORTFOLIO
TABLE 111. STRATASYS (ISRAEL): KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY TYPE
FIGURE 012. FLUOROPOLYMERS (FP) MARKET OVERVIEW (2016-2028)
FIGURE 013. HIGH PERFORMANCE POLYAMIDES (HPPA) MARKET OVERVIEW (2016-2028)
FIGURE 014. POLYARYLETHERKETONES (PAEK) MARKET OVERVIEW (2016-2028)
FIGURE 015. POLYPHENYLENE SULFIDES (PPS) MARKET OVERVIEW (2016-2028)
FIGURE 016. POLYETHERIMIDE (PEI) MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHERS (PAI; PFA; ETFE; AND PEK) MARKET OVERVIEW (2016-2028)
FIGURE 018. HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY APPLICATION
FIGURE 019. MEDICAL EQUIPMENT & TOOLS MARKET OVERVIEW (2016-2028)
FIGURE 020. MEDICAL SUPPLIES MARKET OVERVIEW (2016-2028)
FIGURE 021. DRUG DELIVERY MARKET OVERVIEW (2016-2028)
FIGURE 022. PROSTHESIS & IMPLANTS MARKET OVERVIEW (2016-2028)
FIGURE 023. THERAPEUTIC SYSTEM MARKET OVERVIEW (2016-2028)
FIGURE 024. OTHERS (ARTIFICIAL CORNEA; CHEMICAL TANKS; STERILIZING BOXES; SECRETION BOTTLES; AND SURGICAL THEATER LUMINARIES) MARKET OVERVIEW (2016-2028)
FIGURE 025. NORTH AMERICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. EUROPE HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. ASIA PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. SOUTH AMERICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
Please Wait...

Frequently Asked Questions :

What would be forecast period in the market research report?
The forecast period in the market research report is 2021-2027.
Who are the key players in High Performance Medical Plastics market?
The key players mentioned are Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastic (France), Celanese Corporation (US), Trelleborg (Sweden), Tekni-Plex (US), Biomerics (US), RTP Company (US), Gujrat Fluorochemicals Ltd. (India), Drake Medical Plastic (US), Performance Plastic Ltd. (US), Bollinger Group (Austria), China Array Plastic (China), Extra Plastic Industry Co. Ltd. (Taiwan), Spectrum Plastic Group (Atlanta), Stratasys (Israel).
What are the segments of High Performance Medical Plastics market?
The High Performance Medical Plastics market is segmented into application type, product type and region. By Application type, the market is categorized into Medical Equipment & Tools, Medical Supplies, Drug Delivery, Prosthesis & Implants, Therapeutic System, Others (Artificial Cornea; Chemical Tanks; Sterilizing Boxes; Secretion Bottles; And Surgical Theater Luminaries). By product type, it is classified into Fluoropolymers (FP), High Performance Polyamides (HPPA), Polyaryletherketones (PAEK), Polyphenylene Sulfides (PPS), Polyetherimide (PEI), Others (PAI; PFA; ETFE; and PEK) and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the High Performance Medical Plastics market?
High Performance Medical Plastics Market size is projected to reach xxxx units by 2027 from an estimated xxxx unit in 2020, growing at a CAGR of xx% globally.
How big is the High Performance Medical Plastics market?
The global High Performance Medical Plastics market size was estimated at USD XX billion in 2020 and is expected to reach USD XX billion in 2027.